Photo of Dr Anish Bahra

Dr Anish Bahra

Telephone:

Email:

Location:

  • National Hospital for Neurology and Neurosurgery

GMC/GDC number:

3333484

Professional background

Dr Anish Bahra is a consultant neurologist with a specialist interest in headache. Dr Bahra is part of the facial pain multidisciplinary service at the Pain Management Centre, UCLH. Prior to this post Dr Bahra ran a tertiary headache clinic at the National Hospital for Neurology and Neurosurgery from 2003 to 2022. Her original research was at UCL in cluster headache. She has since expanded the expertise to all types of head and facial pain disorders. She is a council member of the British Association for the Study of Headache (BASH), and part of the BASH Guideline group which published the updated national headache guidelines in 2019. She represents the headache subspeciality on the editorial board of the ACNR (Advances in Clinical Neurosciences and Rehabilitation), Brain Research UK Scientific Advisory Board, and both Association of British Neurology and International Headache Society specialist interest groups. She is a Life Member and currently a trustee of OUCH, the Organisation for the Study of Headache.

Specialties

Research interests

Trigeminal and other cranial neuralgias, trigeminal autonomic cephalalgias, chronic migraine, secondary headaches.

Publications

10 most recent publications:

  • Goadsby PJ, Bahra A, Silver N, et al. High flow versus ultra-high flow (demand valve) oxygen delivery in cluster headache:
  • A patient experience survey by the Organization for Understanding Cluster Headache-UK ( OUCH-UK ). Cephalalgia Reports 2025; 8. DOI: 10.1177/25158163251339439.
  • Haider S, Shoai M, Shah R, et al. Novel screening tool for secondary headache in acute care-A pilot study. Clin Med (Lond) 2024; 24: 100005. 2024/03/15. DOI: 10.1016/j.clinme.2023.100005.
  • Chong MS, Bahra A and Zakrzewska JM. Guidelines for the management of trigeminal neuralgia. Cleve Clin J Med 2023; 90: 355-362. 20230601. DOI: 10.3949/ccjm.90a.22052.
  • Bahra A. Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment. Cephalalgia 2023; 43: 3331024231214239. 2023/11/11 20:42. DOI: 10.1177/03331024231214239.
  • Lobo R, Wang M, Lobo S, et al. Time to retire 'New daily persistent headache': Mode of onset of chronic migraine and tension-type headache. Cephalalgia 2022; 42: 385-395. 2021/09/29. DOI: 10.1177/03331024211044440.
  • Farag M and Bahra A. Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders. Headache 2022; 62: 383-388. 2022/03/13. DOI: 10.1111/head.14282.
  • Atraszkiewicz D, Ito R and Bahra A. The efficacy of botulinum toxin type-A for intractable chronic migraine patients with no pain-free time. Br J Pain 2022; 16: 41-49. 2022/02/04. DOI: 10.1177/20494637211014544.
  • Ceronie B, Hart T, Belete D, et al. Isolated headache is not a reliable indicator for brain cancer: the 2-week wait pathway for suspected CNS malignancies. Clin Med (Lond) 2021; 21: e648-e655. 2021/12/05. DOI: 10.7861/clinmed.CM-2021-0223.
  • Bahra A and Evans RW. The Secondary Headaches. Cephalalgia 2021; 41: 427-430. 2021/03/18. DOI: 10.1177/0333102421999996.